Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-01 5:14 pm Purchase | 2021-12-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 118,961,206 9.500% | 7,777,872 (+7.00%) | Filing History |
| 2021-09-10 12:17 pm Purchase | 2021-08-10 | 13G | Tango Therapeutics, Inc. TNGX | GILEAD SCIENCES INC. GILD | 4,854,443 5.500% | 4,854,443 (New Position) | Filing History |
| 2021-02-16 3:46 pm Unchanged | 2021-02-16 | 13G | Gilead Sciences, Inc. GILD | Capital Research Global Investors | 121,672,399 9.700% | 0 (Unchanged) | Filing History |
| 2021-02-16 1:27 pm Purchase | 2021-02-16 | 13G | Gilead Sciences, Inc. GILD | Capital Research Global Investors | 121,672,399 9.700% | 36,539,514 (+42.92%) | Filing History |
| 2021-02-12 4:36 pm Purchase | 2020-12-31 | 13G | HOOKIPA Pharma Inc. HOOK | GILEAD SCIENCES INC. GILD | 209,280 7.200% | 42,553 (+25.52%) | Filing History |
| 2021-02-10 10:57 am Sale | 2020-12-31 | 13G | Gilead Sciences, Inc. GILD | The Vanguard Group | 102,787,017 8.200% | -984,831 (-0.95%) | Filing History |
| 2021-02-02 4:51 pm Sale | 2021-01-31 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 22,723,156 35.000% | -6,775,268 (-22.97%) | Filing History |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 111,183,334 8.900% | 4,709,740 (+4.42%) | Filing History |
| 2020-10-26 4:33 pm Purchase | 2020-10-16 | 13G | Jounce Therapeutics, Inc. JNCE | GILEAD SCIENCES INC. GILD | 5,539,727 13.900% | 5,539,727 (New Position) | Filing History |
| 2020-07-17 2:01 pm Purchase | 2020-07-08 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 29,498,424 35.000% | 29,498,424 (New Position) | Filing History |